HIPEC Combined With SOX and Sintilimab in the Treatment of Advanced Gastric Cancer With Peritoneal Metastasis
NCT06213519
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
69
Enrollment
OTHER
Sponsor class
Conditions
Peritoneal Metastases
Gastric Cancer
Interventions
DRUG:
S-1, Oxaliplatin sintilimab HIPEC
Sponsor
Sichuan University